Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
Gene Expression Profiling on CML Patients with Philadelphia Translocation
الكشف عن نمط التعبير الجيني على مرضى سرطان الدم المزمن في ناقلات كروموسومات الفيلادلفيا
Subject
:
Faculty of Applied Medical Sciences
Document Language
:
Arabic
Abstract
:
Background: Tyrosine kinase inhibitors (TKIs) and other targeted medicines are crucial in the management of chronic myeloid leukemia (CML) patients' treatment. However, some patients do continue to experience less favorable outcomes and exhibit resistance to therapy. Therefore, the aim of our study is to conduct whole transcriptome sequencing to assess the differential gene expression profile in CML cases according to the patient’s response to TKI-based therapy. Method: Ten blood samples from CML patients at two different phases (diagnosis stage and relapse stage) were collected. All samples were subjected to RNA extraction, and ≤20 µg of RNA was used for NGS sequencing. The DESeq2 R software was used to do the data analysis. Result: A list of 499 genes was found to have significantly differential expression levels among the two study groups. Around 122 genes were found to be upregulated, whereas 377 were found to be downregulated. There was a highly significant deregulation of NTRK2 (>+5 FoldChange) and KRT17 (< -5 FoldChange) expression compared to other genes. The majority of the expressed genes are involved in the cell cycle, PI3K-AKT signaling pathway, cellular senescence, oxidative phosphorylation, microRNA in cancer, FOXO and P53 signaling pathways, as well as other biological processes. Conclusions: Our findings reveal the association between the signaling pathways and treatment resistance in CML cases. These pathways also showed a higher performance in downstream signaling of the TKI target, BCR-ABL. Few target genes require further validation in a larger cohort to confirm their association with TKI resistance. This research finding sheds light on several BCR-ABL independent mechanisms that could be associated with the resistance mechanism, which will improve future treatment of CML patients. Key Words: Chronic Myeloid Leukemia (CML), Philadelphia, Tyrosine Kinase inhibitor, gene expression, Next generation sequencing (NGS).
Supervisor
:
Dr. Heba A Alkhatabi
Thesis Type
:
Master Thesis
Publishing Year
:
1444 AH
2023 AD
Added Date
:
Monday, July 3, 2023
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
صفاء محمد الدهلوي
AlDahlawi, Safaa Mohammed
Researcher
Master
Files
File Name
Type
Description
49248.pdf
pdf
Back To Researches Page